• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体包裹的接触性变应原的经皮渗透特性及释放动力学

Percutaneous penetration characteristics and release kinetics of contact allergens encapsulated in ethosomes.

作者信息

Madsen Jakob Torp, Vogel Stefan, Johansen Jeanne Duus, Sørensen Jens Ahm, Andersen Klaus Ejner, Nielsen Jesper Bo

机构信息

Department of Dermatology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.

出版信息

Cutan Ocul Toxicol. 2011 Mar;30(1):38-44. doi: 10.3109/15569527.2010.521220. Epub 2010 Nov 23.

DOI:10.3109/15569527.2010.521220
PMID:21091289
Abstract

BACKGROUND

Formulation of the contact allergens dinitrochlorobenzene and isoeugenol in ethanolic liposomes (ethosomes) increases their sensitizing properties in the local lymph node assay compared with an ethanol-water formulation of the allergens. Likewise, isoeugenol and methyldibromo-glutaronitrile formulated in ethosomes enhanced the patch test reactions in sensitized human volunteers. The relationship between the percutaneous penetration/absorption and sensitization/elicitation phases of contact allergy is not well elucidated.

OBJECTIVE

The aim of this study was to investigate whether the observed increased sensitizing and elicitation properties following the formulation of selected contact allergens in ethosomes could be explained by a change in release kinetics of the allergens and their pattern of percutaneous penetration and absorption as well as allergen deposition in epidermis and dermis.

METHODS

Release kinetics were studied using dialysis bags, and samples were taken at selected time points until equilibrium was reached. Percutaneous absorption and penetration were studied using human skin on Franz cells, and receptor fluid samples were taken at selected time points. Experiments were terminated after 24 hours, and deposition of allergen in epidermis and dermis was measured. Maximum flux and lag time were calculated.

RESULTS

Ethosome formulation decreased the release of both allergens compared with the ethanol-water formulation. Ethosome formulation of dinitrochlorobenzene increased its percutaneous penetration but reduced the percutaneous penetration of isoeugenol compared with control formulations. Likewise, all other calculated parameters showed an opposite trend for the 2 allergens in ethosomes and ethanol-water.

CONCLUSIONS

The present study demonstrates that identical ethosomes affect the percutaneous penetration characteristics of 2 allergens differently. Thus, our results indicate that each combination of an allergen and a vehicle needs to be evaluated separately. The exact mechanistic relationship between percutaneous penetration, release kinetics, and allergenicity of chemicals in various vehicles remains to be clarified.

摘要

背景

与过敏原的乙醇 - 水制剂相比,将接触性过敏原二硝基氯苯和异丁香酚制成乙醇脂质体(醇质体)后,在局部淋巴结试验中其致敏特性增强。同样,制成醇质体的异丁香酚和甲基二溴戊二腈在致敏的人类志愿者中增强了斑贴试验反应。接触性过敏的经皮渗透/吸收与致敏/激发阶段之间的关系尚未得到充分阐明。

目的

本研究的目的是调查将选定的接触性过敏原制成醇质体后观察到的致敏和激发特性增加,是否可以通过过敏原释放动力学的变化、其经皮渗透和吸收模式以及过敏原在表皮和真皮中的沉积来解释。

方法

使用透析袋研究释放动力学,并在选定的时间点取样,直至达到平衡。使用Franz扩散池上的人体皮肤研究经皮吸收和渗透,并在选定的时间点采集受体液样本。24小时后终止实验,并测量过敏原在表皮和真皮中的沉积。计算最大通量和滞后时间。

结果

与乙醇 - 水制剂相比,醇质体制剂降低了两种过敏原的释放。与对照制剂相比,二硝基氯苯的醇质体制剂增加了其经皮渗透,但降低了异丁香酚的经皮渗透。同样,对于醇质体和乙醇 - 水制剂中的两种过敏原,所有其他计算参数均显示出相反的趋势。

结论

本研究表明相同的醇质体对两种过敏原的经皮渗透特性影响不同。因此,我们的结果表明,每种过敏原与载体的组合都需要单独评估。各种载体中化学物质的经皮渗透、释放动力学和致敏性之间的确切机制关系仍有待阐明。

相似文献

1
Percutaneous penetration characteristics and release kinetics of contact allergens encapsulated in ethosomes.脂质体包裹的接触性变应原的经皮渗透特性及释放动力学
Cutan Ocul Toxicol. 2011 Mar;30(1):38-44. doi: 10.3109/15569527.2010.521220. Epub 2010 Nov 23.
2
Ethosome formulations of known contact allergens can increase their sensitizing capacity.已知接触过敏原的 ethosome 制剂可以增加其致敏能力。
Acta Derm Venereol. 2010 Jul;90(4):374-8. doi: 10.2340/00015555-0874.
3
Ethosome formulation of contact allergens may enhance patch test reactions in patients.接触过敏原的 ethosome 制剂可能会增强患者的斑贴试验反应。
Contact Dermatitis. 2010 Oct;63(4):209-14. doi: 10.1111/j.1600-0536.2010.01779.x. Epub 2010 Aug 20.
4
Encapsulating contact allergens in liposomes, ethosomes, and polycaprolactone may affect their sensitizing properties.将接触性变应原包裹于脂质体、醇质体和聚己内酯中可能会影响它们的致敏特性。
Cutan Ocul Toxicol. 2011 Jun;30(2):116-23. doi: 10.3109/15569527.2010.540765. Epub 2011 Jan 4.
5
Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.利多卡因碱质体的配方与评价及其经皮给药。
Anesth Analg. 2013 Aug;117(2):352-7. doi: 10.1213/ANE.0b013e3182937b74. Epub 2013 Jun 6.
6
Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes.醇质体促进亲脂性药物经皮渗透的机制。
Int J Nanomedicine. 2017 Apr 26;12:3357-3364. doi: 10.2147/IJN.S134708. eCollection 2017.
7
The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat.接触性变应原二硝基氯苯(DNCB)与Th2倾向型棕色挪威大鼠的呼吸道过敏反应
Toxicology. 2008 Apr 18;246(2-3):213-21. doi: 10.1016/j.tox.2008.01.013. Epub 2008 Feb 2.
8
Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.通过乙醇脂质体进行抗银屑病药物的真皮和透皮给药。
J Control Release. 2007 Nov 6;123(2):148-54. doi: 10.1016/j.jconrel.2007.08.005. Epub 2007 Aug 16.
9
Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.用于甘草酸铵经皮给药的醇质体:通过人体皮肤的体外经皮渗透及对人体志愿者的体内抗炎活性
J Control Release. 2005 Aug 18;106(1-2):99-110. doi: 10.1016/j.jconrel.2005.04.007.
10
A study of the enhanced sensitizing capacity of a contact allergen in lipid vesicle formulations.脂质囊泡配方中接触变应原增强致敏能力的研究。
Toxicol Appl Pharmacol. 2011 May 1;252(3):221-7. doi: 10.1016/j.taap.2011.02.010. Epub 2011 Feb 16.

引用本文的文献

1
A randomised clinical trial study assessing the efficacy of 5% losartan potassium loaded in ethosomal gel to treat human keloids: a trial protocol.一项评估 5% 洛沙坦钾载入醇质体凝胶治疗人类瘢痕疙瘩疗效的随机临床试验研究:试验方案。
Trials. 2024 Jan 2;25(1):12. doi: 10.1186/s13063-023-07880-2.
2
Nano-titanium dioxide modulates the dermal sensitization potency of DNCB.纳米二氧化钛可调节 DNCB 的皮肤致敏效力。
Part Fibre Toxicol. 2012 May 23;9:15. doi: 10.1186/1743-8977-9-15.